首页 | 本学科首页   官方微博 | 高级检索  
     

  We describe the first case of biopsy-proven renal tubular injuryassociated with anagrelide.   A 60-year-old man with a 35 year history of Crohn's diseasewas diagnosed with essential thrombocytosis (ET) following aunilateral renal artery thrombosis in May 2003. His plateletcount at the time of diagnosis with ET was 1.3 million cells/mm3. He began taking 0.5 mg oral anagrelide twice daily, increasingthe dose to 1 mg each morning and 0.5 mg each evening over

Renal tubular injury associated with anagrelide use.
Authors:Graham E J Rodwell  Megan L Troxell  Richard A Lafayette
Affiliation:Division of Nephrology, Stanford University School of Medicine, 300 Pasteur Drive, S161, MC5114, Stanford, CA 94305-5114, USA. graham.rodwell@stanford.edu
Abstract:
  Introduction  Case
Keywords:acute renal failure   acute tubular necrosis   side effects
本文献已被 Oxford 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号